| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.60M | — |
| Operating expense | — | — |
| Net income | -127.55M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4DN.F returned +56.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +45.6% |
| 1 year | +56.7% |
| 5 years | -53.5% |
| All-time high | €68.98 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 4DN.F would be worth today ›No. Denali Therapeutics Inc. has not paid a dividend in the past 12 months.
Denali Therapeutics Inc. is part of the Healthcare sector.
Denali Therapeutics Inc. has a market cap of 3.29B EUR, based on the latest quote.
Denali Therapeutics Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
